{"id":4447,"date":"2023-09-27T14:44:53","date_gmt":"2023-09-27T14:44:53","guid":{"rendered":"https:\/\/regtechafrica.com\/healthcare\/?p=4447"},"modified":"2023-09-27T14:45:24","modified_gmt":"2023-09-27T14:45:24","slug":"global-european-commission-grants-approval-to-sandoz-for-ms-drug","status":"publish","type":"post","link":"https:\/\/regtechafrica.com\/healthcare\/global-european-commission-grants-approval-to-sandoz-for-ms-drug\/","title":{"rendered":"Global: European Commission Grants Approval to Sandoz for MS Drug"},"content":{"rendered":"<p>In a significant development, Novartis announced on Tuesday (September 26, 2023) that its forthcoming generic-drugs division, Sandoz, has secured approval from the European Commission for Tyruko (natalizumab). This drug is designed to address relapsing forms of multiple sclerosis.<\/p>\n<p>Tyruko marks a pioneering milestone as the first biosimilar for the treatment of multiple sclerosis in Europe. Novartis confirmed in a statement that it has received approval for all indications of the reference medicine.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a significant development, Novartis announced on Tuesday (September 26, 2023) that its forthcoming generic-drugs division, Sandoz, has secured approval from the European Commission for Tyruko (natalizumab). This drug is&hellip;<\/p>\n","protected":false},"author":1,"featured_media":4450,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[73,78],"tags":[],"class_list":["post-4447","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-global","category-regulatory"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/regtechafrica.com\/healthcare\/wp-content\/uploads\/2023\/09\/Sandoz-MS-drug-receives-approval-from-European-Commission.jpg?fit=1200%2C675&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/4447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/comments?post=4447"}],"version-history":[{"count":2,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/4447\/revisions"}],"predecessor-version":[{"id":4452,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/posts\/4447\/revisions\/4452"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/media\/4450"}],"wp:attachment":[{"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/media?parent=4447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/categories?post=4447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regtechafrica.com\/healthcare\/wp-json\/wp\/v2\/tags?post=4447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}